(Q28269764)

English

ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

0 references

ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients (English)

0 references

0 references

renal cell carcinoma

1 reference

based on heuristic

inferred from title

Jennelle C. Hodge

2

object named as

Jennelle C Hodge

0 references

author name string

William R Sukov

1

0 references

Christine M Lohse

3

0 references

Monica K Akre

4

0 references

Bradley C Leibovich

5

0 references

R Houston Thompson

6

0 references

John C Cheville

7

0 references

language of work or name

0 references

publication date

November 2012

0 references

Modern Pathology

0 references

25

0 references

11

0 references

1516-25

0 references

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2012.107

21 April 2017

Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2012.107

21 April 2017

Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2012.107

21 April 2017

Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2012.107

21 April 2017

TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2012.107

21 April 2017

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2012.107

21 April 2017

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2012.107

21 April 2017

Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2012.107

21 April 2017

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2012.107

21 April 2017

ALK rearrangement in sickle cell trait-associated renal medullary carcinoma

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2012.107

21 April 2017

Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2012.107

21 April 2017

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.107

21 April 2017

Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.107

21 January 2018

ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.107

21 January 2018

The anaplastic lymphoma kinase in the pathogenesis of cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.107

21 January 2018

The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.107

21 January 2018

Fusion tyrosine kinase NPM-ALK Deregulates MSH2 and suppresses DNA mismatch repair function novel insights into a potent oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.107

21 January 2018

Pathological, immunohistochemical and cytogenetic features of papillary renal cell carcinoma with clear cell features

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.107

21 January 2018

A Distinctive Subset of PEComas Harbors TFE3 Gene Fusions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.107

21 January 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.107

21 January 2018

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.107

21 January 2018

Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.107

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2012.107

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Dimensions Publication ID

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28269764&oldid=2175170793"